Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 Nov 10;32(2):516–522. doi: 10.1161/ATVBAHA.111.237040

Table 1.

Baseline characteristics

Without Event With Event
Demographics and Cardiovascular Risk Factors
Age (years) 63±11 67±10
Male (%) 67 64
Diabetes mellitus (%) 29 41
Hypertension (%) 70 75
Smokers (Former/Current, %) 65 70
Prior myocardial infarction (%) 31 44

Laboratory Data
LDL cholesterol [mg/dL] 95 (77–116) 95 (77–116)
HDL cholesterol [mg/dL] 34 (28–41) 33 (27–40)
Triglycerides [mg/dL] 114 (83–162) 120 (84–163)
Total leukocyte count [WBCP/hpf] 6.04 (5.02–7.34) 6.21 (5.07–7.53)
Uric acid [mg/dL] 6.1 (5.1–7.2) 6.5 (5.5–7.8)
hsCRP [mg/L] 1.95 (0.90–4.36) 3.50 (1.46–7.22)
Myeloperoxidase [pg/mL] 102 (70–189) 115 (74–227)
Creatinine clearance [ml/min/1.73m2] 102 (79–127) 86 (59–114)

Baseline Medications
Aspirin (%) 74 67
Beta-adrenergic blockers (%) 61 63
Angiotensin converting enzyme inhibitors (%) 48 58
Statin therapy (%) 60 55

Events defined as death, myocardial infarction, or stroke. Values expressed in median (interquartile ranges)